Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-25 @ 4:26 AM
NCT ID:
NCT03069820
Eligibility Criteria:
Inclusion Criteria:
* Patients with advanced nasopharyngeal carcinoma.
* Patients scheduled to receive the first line, first cycle TP (docetaxel and cisplatin) chemotherapy.
* Normal liver function biomarkers including ALT,AST,ALP,TBIL before recruitment.
* Minimum age of 18 years.
* Life expectancy at least 3 months.
Exclusion Criteria:
* Patients previously received chemotherapy
* Patients who have liver metastases.
* Patients who take other drugs that may affect liver function
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03069820
Study Brief:
Protocol Section:
NCT03069820